文献速递淋巴瘤

英国大型B细胞淋巴瘤患者中CAR-T可及性与结局的种族及社会经济剥夺差异分析

CAR T access and outcomes in large B-cell lymphoma according to ethnicity and socioeconomic deprivation in the UK.
PubMed 文献 · Br J Haematol · 2025-01-16

该研究分析了英国三个CAR-T中心314例获批三线CD19 CAR-T治疗的大B细胞淋巴瘤患者,发现贫困地区患者输注率较低(73% vs 86%,p=0.04),意向性治疗1年总生存较差(44.5% vs 58%,p=0.02),但缓解率、毒性、无进展生存或非复发死亡在种族或剥夺程度上无差异。

要点

  • 贫困地区患者CAR-T输注率较低(73% vs 86%,p=0.04)。
  • 贫困地区患者意向性治疗1年OS较差(44.5% vs 58%,p=0.02)。
  • 缓解率、毒性、PFS或非复发死亡在种族或剥夺程度上无差异。

核心结论

  • 数据提示在 socioeconomic 和种族异质性的真实世界人群中,接受CD19 CAR-T治疗的患者结局相似。
  • 结果证明英国国家配送系统内CAR-T广泛可及,但贫困社区的高脱落率和潜在区域转诊障碍应进一步研究。

研究设计与样本

  • 分析英国三个大型CAR-T中心314例获批三线CD19 CAR-T治疗的大B细胞淋巴瘤患者的种族、社会经济剥夺和转诊模式。
  • 队列研究,样本量为314例。

主要发现

  • 贫困地区患者输注率较低(73% vs 86%,p=0.04)。
  • 在意向性治疗分析中,贫困地区患者1年总生存较差(高剥夺 vs 低剥夺:44.5% vs 58%,p=0.02),可能反映一般健康差异和该组较高的脱落率。
  • CAR-T缓解率、毒性、无进展生存或非复发死亡在种族或剥夺程度上相似。
  • 未发现按种族的转诊障碍证据,但在三个中心中的两个观察到社会经济贫困患者可能存在区域障碍。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 贫困社区的高脱落率和潜在区域转诊障碍应进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Data on the impact of ethnic and socioeconomic factors on Chimeric antigen receptor (CAR) T-cell therapy (access and outcomes are limited, but key to understand whether results from the registration trials are generalizable to real-world patient populations. Here, we analysed ethnicity, socioeconomic deprivation and referral patterns in a cohort of 314 large B-cell lymphoma patients approved for third-line CD19 CAR-T across three large UK CAR-T centres. Patients from deprived areas had a lower infusion rate compared to low deprivation areas (73% vs. 86%, p = 0.04). CAR-T response rates, toxicities, progression-free survival or non-relapse mortality were similar with respect to ethnicity or deprivation. We did not find evidence of referral barriers according to ethnicity, but potential regional barriers for socioeconomically deprived patients in two of three centres. Intention-to-treat overall survival was significantly inferior in patients from deprived areas (1-year OS 44.5% vs. 58% for high vs. low deprivation; p = 0.02), likely reflecting general health disparities and higher drop-out rates in this group. Our data suggest similar outcomes of CD19 CAR-T-treated patients across a socioeconomically and ethnically heterogeneous real-world population. Results demonstrate broad access to CAR-T within the UK national delivery system, but the high drop-out rate and potential regional referral barriers for deprived communities should be further investigated.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Dragoi D, Cusworth S, Oldham L, et al. CAR T access and outcomes in large B-cell lymphoma according to ethnicity and socioeconomic deprivation in the UK. Br J Haematol. 2025. PMID: 39821591. doi:10.1111/bjh.19997

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。